Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Aspergillosis

Trial Information

A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074 AM1)

Official Title: A Multicenter, Noncomparative, Open-label Study to Estimate the Safety, Efficacy, and Pharmacokinetics of MK-0991 (Caspofungin) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections

Summary

The study estimates the safety, efficacy, and pharmacokinetics of caspofungin (MK-0991) in Japanese children and adolescents with documented Candida or Aspergillus infections.

Phase: Phase 2

Sponsor: Merck

Overall Contacts:

Toll Free Number
1-888-577-8839

Locations (1)

Country State City Zip Facility and Contact
Japan Chiyoda-Ku, Tokyo 102-8667 MSD K.K.
Japan Call Center
81-3-6272-1957

NCT ID:NCT01165320

Date Last Changed: March 13, 2013